HCV - Liver Cirrhosis

Pegylated Interferon alfa-2b (PegIntron) Maintenance Monotherapy May Reduce Esophageal Varices in Hepatitis C Patients with Cirrhosis


Liver Disease Progression and Treatment Response in Latino and Asian Patients with Chronic Hepatitis C
12/12/2008

Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation
6/10/08

Natural History of HCV-Related Cirrhosis after Liver Transplantation
5/08/08

Pegylated Interferon plus Ribavirin for Patients with HCV-related Liver Cirrhosis
3/11/08

Non-Invasive Ways to Assess Liver Disease: Studies Test Alternatives to Liver Biopsy
2/05/08

Human Genetic Variation May Protect Against HCV-related Liver Disease Progression
1/04/08

Non-invasive FibroTest and FibroScan Predict Liver Cirrhosis Better than Earlier Stages of Fibrosis in Hepatitis C Patients
12/11/07

CD4 Cell Count Preferred over CD4 Cell Percentage for Monitoring HIV Disease Progression in People with Cirrhosis  
8/21/07

Treatment with Pegasys Plus Ribavirin in Genotype 2/3 Chronic Hepatitis C Patients with Liver Cirrhosis  
5/22/07

Transient Elastography as a Non-invasive Method for Predicting Portal Hypertension in Patients with Hepatitis C-related Cirrhosis
5/18/07

Racial Disparities in Treatment of Patients with Cirrhosis and Complications of Portal Hypertension
5/15/07

Sustained Response to Interferon Monotherapy Reduces Rates of Liver Cancer and Death in Patients with HCV-related Cirrhosis
3/27/07